Oxycodone hydrochloride 10 mg and 20 mg: Supply issue
The supplier of oxycodone hydrochloride controlled-release tablets has advised that they are experiencing supply constraints impacting the 20 mg strength.
5 August 2021 Update
10 mg Oxycodone Sandoz has been resupplied. We anticipate the 20 mg Oxycodone Sandoz will be resupplied by the end of September.
Alternative product available
We have listed the OxyContin brand of oxycodone (10 mg and 20 mg tablets) to help cover this supply issue. A small volume of this product is being air freighted from Australia. This product is Medsafe approved. However, it does not quite meet labelling requirements.
It does not have the following statements:
- Controlled Drug B3
- Directions for Use: 1 tablet to be taken every 12 hours or as directed by physician
Oxycontin Tab controlled-release
- 10 mg (Pharmacode 2613824) $11.50 per 28
- 20 mg (Pharmacode 2613832) $13.25 per 28
We are working with the supplier to understand re-supply timeframes.
Alternative products listed
We have listed Sandoz's alternative products to ensure continuity of supply. These are available in a variety of pack sizes that are listed on the Pharmaceutical Schedule.
These alternative products are not Medsafe approved, as such they need to be supplied under section 29 of the Medicines Act.
Prescribing and supplying a medicine under section 29
Section 29 of the Medicines Act allows for medicines that are not Medsafe approved to be prescribed and supplied to people. The medicine must be prescribed by someone registered with the Medical Council of New Zealand – eg doctors.
We know a section 29 medicine is not ideal. In this case, however, the alternative would be for patients to have no oxycodone in these strengths.
We apologise for any inconvenience this causes.
Who to contact
If you have any questions about this supply issue, please contact Sandoz:
- phone: 0800 354 335
- email: email@example.com
If you have any questions about funding of these medicines, contact firstname.lastname@example.org